Company halting further development of imvotamab (CD20 x CD3) and IGM-2644 (CD38 x CD3) – – Company reducing its workforce by 73% – – Cash and investments of $183.8 million (unaudited) as of December ...
CES 2025, the annual consumer tech conference held in Las Vegas, is upon us — and this is where you can find all of our live updates. Over the next few days, TechCrunch reporters will be on the ground ...
Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) is pleased to announce amendments to its Manufacturing Services Agreement with CytoImmune Therapeutics ...
Alabama public school students who repeatedly violated rules restricting the use of cell phones in classrooms would be subject to fines under a bill pre-filed for the legislative session, which is ...